HAEMONETICS CORP
S-8, 1998-08-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ENERCORP INC, 8-K, 1998-08-14
Next: HAEMONETICS CORP, S-8, 1998-08-14




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      under
                           THE SECURITIES ACT OF 1933
                             HAEMONETICS CORPORATION
               (Exact name of issuer as specified in its charter)

                            Massachusetts 04-2882273
          (State of Incorporation) (IRS Employer Identification Number)

          400 Wood Road, Braintree, Massachusetts 02814 (617) 848-7100
          -------------------------------------------------------------
          (Address and telephone number of Principal Executive Offices)

                             HAEMONETICS CORPORATION

                        1998 Employee Stock Purchase Plan
                            (Full title of the Plan)

                        Alicia R. Lopez, General Counsel
                             Haemonetics Corporation
                                  400 Wood Road
                         Braintree, Massachusetts 02184
                                 (617) 848-7100

              (Name, address and telephone number of agent service)

                                    Copy to:
                                Mary Ellen O'Mara
                           Hutchins, Wheeler & Dittmar
                           A Professional Corporation
                               101 Federal Street
                           Boston, Massachusetts 02110

                         CALCULATION OF REGISTRATION FEE


<TABLE>
                                                 Proposed                Proposed
                                                 Maximum                 Maximum
Title of                 Amount                  Offering                Aggregate                Amount of
Securities               to be                   Price                   Offering                 Registration
to be Registered         Registered(1)           Per Share                   Price                     Fee(2)
- ----------------         -------------           ---------               ------------             -----------
<S>                       <C>                     <C>                    <C>                        <C>   
Common Stock,             375,000                 $15.59                 $5,846,250                 $1,725
par value
$.01 per share

</TABLE>

(1)      Also  registered  hereunder  are such  additional  number  of shares of
         Common Stock, presently indeterminable,  as may be necessary to satisfy
         the  antidilution  provisions  of the Plan to which  this  Registration
         Statement relates.

(2)      The registration fee has been calculated on the basis of the average of
         the high and low sale  prices on the New York Stock  Exchange on August
         11, 1998.




<PAGE>



                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

         The Company hereby  incorporates  by reference the documents  listed in
(a) through (c) below.  In addition,  all  documents  subsequently  filed by the
Company  pursuant  to  Section  13(a),  13(c),  14 and  15(d) of the  Securities
Exchange Act of 1934 (prior to the filing of a  Post-Effective  Amendment  which
indicates that all securities  offered have been sold or which  deregisters  all
securities  then  remaining  unsold)  shall  be  deemed  to be  incorporated  by
reference in this Registration  Statement and to be a part thereof from the date
of filing of such documents.

         (a) The Company's  latest annual report filed pursuant to Section 13(a)
or 15(d) of the Securities  Exchange Act of 1934 or the latest  Prospectus filed
pursuant to Rule 424(b) under the Securities Act of 1933,  which contains either
directly or by incorporation by reference audited  financial  statements for the
Company's latest fiscal year for which such statements have been filed.

         (b) All other reports  filed  pursuant to Section 13(a) or 15(d) of the
Securities  Exchange Act of 1934 since the end of the fiscal year covered by the
annual report or the Prospectus referred to in (a) above.

         (c) The description of the Company's Common Stock which is contained in
the  Registration  Statement filed by the Company under the Securities  Exchange
Act of 1934, including any amendment or report filed for the purpose of updating
such description.

Item 4.  Description of Securities

         Inapplicable

Item 5.  Interests of Named Experts and Counsel

         The financial  statements  and schedules  incorporated  by reference in
this   Registration   Statement  have  been  audited  by  Arthur  Andersen  LLP,
independent  public  accountants,  as  indicated  in their  reports with respect
thereto, and are incorporated by reference herein in reliance upon the authority
of said firm as experts in giving said reports.

         The  validity of the  authorization  and  issuance of the Common  Stock
offered  hereby  will be passed  upon for the  Company  by  Hutchins,  Wheeler &
Dittmar, a Professional Corporation, Boston, Massachusetts.

Item 6.  Indemnification of Directors and Officers

         Section 67 of Chapter 156B of the General Laws of the  Commonwealth  of
Massachusetts provides as follows:


                                      - 2 -

<PAGE>



         "Section 67.  Indemnification  of  directors,  officers,  employees and
other  agents  of a  corporation,  and  persons  who  serve  at its  request  as
directors,  officers, employees or other agents of another organization,  or who
serve at its request in any capacity with respect to any employee  benefit plan,
may be provided by it to whatever  extent shall be specified in or authorized by
(i) the articles of organization or (ii) a by-law adopted by the stockholders or
(iii) a vote  adopted  by the  holders  of a  majority  of the  shares  of stock
entitled  to vote on the  election  of  directors.  Except  as the  articles  of
organization  or  by-laws  otherwise  require,  indemnification  of any  persons
referred to in the preceding  sentence who are not directors of the  corporation
may  be  provided  by it  to  the  extent  authorized  by  the  directors.  Such
indemnification  may include payment by the corporation of expenses  incurred in
defending  a civil or  criminal  action or  proceeding  in  advance of the final
disposition of such action or proceeding,  upon receipt of an undertaking by the
person  indemnified  to repay such payment if he shall be  adjudicated to be not
entitled to indemnification under this section which undertaking may be accepted
without reference to the financial ability of such person to make repayment. Any
such indemnification may be provided although the person to be indemnified is no
longer an officer,  director,  employee or agent of the  corporation  or of such
other organization or no longer serves with respect to any such employee benefit
plan.

         No indemnification shall be provided for any person with respect to any
matter as to which he shall have been  adjudicated in any proceeding not to have
acted in good  faith in the  reasonable  belief  that his action was in the best
interest of the corporation or to the extent that such matter relates to service
with  respect  to an  employee  benefit  plan,  in  the  best  interests  of the
participants or beneficiaries of such employee benefit plan.

         The  absence of any express  provision  for  indemnification  shall not
limit any right of indemnification existing independently of this section.

         A  corporation  shall have power to purchase and maintain  insurance on
behalf of any person who is or was a director,  officer, employee or other agent
of the corporation,  or is or was serving at the request of the corporation as a
director,  officer,  employee  or other  agent of another  organization  or with
respect to any employee benefit plan,  against any liability  incurred by him in
any such  capacity,  or arising  out of his  status as such,  whether or not the
corporation would have the power to indemnify him against such liability."

         Article XXIX of the By-Laws of the Company provides as follows:

                                  ARTICLE XXIX

                     Indemnification of Directors and Others

         Section 29.1 Definitions For purposes of this Article XXIX:
         (a) "Director/officer" means any person who is serving or has served as
a Director,  officer or employee of the Corporation  appointed or elected by the
Board of Directors or the  stockholders  of the  Corporation,  or any  Director,
officer  or  employee  of the  Corporation  who is  serving or has served at the
request of the Corporation as a Director, officer, trustee, principal,  partner,
member of a committee, employee or other agent of any other organization,

                                      - 3 -

<PAGE>



or in any capacity with respect to any employee benefit plan of the Corporation
or any of its subsidiaries.

         (b) "Proceeding" means any action,  suit or proceeding,  whether civil,
criminal,  administrative or  investigative,  brought or threatened in or before
any court, tribunal, administrative or legislative body or agency, and any claim
which could be the subject of a Proceeding.

         (c) "Expense"  means any fine or penalty,  and any liability fixed by a
judgment, order, decree or award in a Proceeding,  any amount reasonably paid in
settlement of a Proceeding  and any  professional  fees and other  disbursements
reasonably  incurred in connection  with a Proceeding.  The term "Expense" shall
include any taxes or penalties imposed on a Director/officer with respect to any
employee benefit plan of the Corporation or any of its subsidiaries.

         Section 29.2  Right to Indemnification
         Except as limited by law or as provided  in  Sections  29.3 and 29.4 of
this  Article  XXIX,   each   Director/officer   (and  his  heirs  and  personal
representatives)  shall be  indemnified by the  Corporation  against any Expense
incurred by him in connection  with each Proceeding in which he is involved as a
result of his serving or having served as a Director/officer.

         Section 29.3  Indemnification not Available
         No indemnification shall be provided to a Director/officer with respect
to a Proceeding as to which it shall have been  adjudicated  that he did not act
in good faith in the reasonable belief that his action was in the best interests
of the  Corporation,  or, to the extent that such Proceeding  relates to service
with  respect  to an  employee  benefit  plan,  in  the  best  interests  of the
participants or beneficiaries of such employee benefit plan.

         Section 29.4  Compromise or Settlement
         In the event  that a  Proceeding  is  compromised  or  settled so as to
impose  any  liability  or  obligation  on  a   Director/officer   or  upon  the
Corporation,  no indemnification  shall be provided as to said  Director/officer
with  respect  to such  Proceeding  if such  Director/officer  shall  have  been
adjudicated  not to have acted in good faith in the  reasonable  belief that his
action was in the best interests of the Corporation, or, to the extent that such
Proceeding  relates to service with respect to an employee  benefit plan, in the
best interests of the  participants or  beneficiaries  of such employee  benefit
plan.

         Section 29.5  Advances
         The Corporation shall pay sums on account of indemnification in advance
of a final  disposition  of a Proceeding  upon receipt of an  undertaking by the
Director/officer to repay such sums if it is subsequently established that he is
not entitled to indemnification pursuant to Sections 29.3 and 29.4 hereof, which
undertaking may be accepted without  reference to the financial  ability of such
person to make repayment.

         Section 29.6  Not Exclusive
         Nothing  in  this  Article  XXIX  shall  limit  any  lawful  rights  to
indemnification existing independently of this Article 29.


                                      - 4 -

<PAGE>



         Section 29.7  Insurance
         The  provisions  of this  Article XXIX shall not limit the power of the
Board of  Directors to authorize  the purchase and  maintenance  of insurance on
behalf of any Director/officer against any liability incurred by him in any such
capacity,  or arising out of his status as such,  whether or not the Corporation
would have the power to indemnify him against such liability  under this Article
XXIX.

Item 7.           Exemption from Registration Claimed

                  Inapplicable

Item 8.  Exhibits

NumberDescription

  4A            Haemonetics Corporation 1998 Employee Stock Purchase Plan

  5             Opinion  of  Hutchins,   Wheeler  &  Dittmar,   a   Professional
                Corporation,  as to  legality  of shares  being  registered  and
                consent.

 23             Consents of Experts - included in Registration Statement under 
                heading "Consent of Independent Public Accountants."

Item 9.         Undertakings

        The undersigned Registrant hereby undertakes the following:

        (a)     The undersigned Registrant hereby undertakes:

                (1) To file,  during  any  period  in which  offers or sales are
being made, a post-effective amendment to this registration statement:

                       (i)     To include any prospectus required by Section 
                               10(a)(3) of the
                               Securities Act of 1933;

                      (ii)     To reflect in the  prospectus any facts or events
                               arising   after   the   effective   date  of  the
                               registration   statement   (or  the  most  recent
                               post-effective    amendment    thereof)    which,
                               individually  or in the  aggregate,  represent  a
                               fundamental  change in the  information set forth
                               in the registration statement;

                     (iii)     To include any material  information with respect
                               to  the  plan  of  distribution   not  previously
                               disclosed  in the  registration  statement or any
                               material  change  to  such   information  in  the
                               registration statement.

Provided,  however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information  required  to be  included in a  post-effective  amendment  by those
paragraphs is contained in

                                      - 5 -

<PAGE>



periodic reports filed by the registrant pursuant to section 13 or section 15(d)
of the Securities Exchange Act of 1934 that are incorporated by reference in the
registration statement.

                (2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

                (3) To remove  from  registration  by means of a  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.

        (b) The undersigned  registrant  hereby undertakes that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to section  13(a) or section 15(d) of the
Securities  Exchange  Act of 1934  (and,  where  applicable,  each  filing of an
employee  benefit  plan's  annual  report  pursuant  to  section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

        (c) The  undersigned  registrant  hereby  undertakes,  that,  insofar as
indemnification  for liabilities arising under The Securities Act of 1933 may be
permitted to  directors,  officers  and  controlling  persons of the  registrant
pursuant to the foregoing  provisions,  or otherwise,  the  registrant  has been
advised  that in the opinion of the  Securities  and  Exchange  Commission  such
indemnification  is  against  public  policy  as  expressed  in the  Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the registrant of expenses incurred
or paid by a director,  officer or  controlling  person of the registrant in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.



                                      - 6 -

<PAGE>



                                   SIGNATURES

        Pursuant  to  the  requirements  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in Braintree, Massachusetts on August 11, 1998.

                                                  HAEMONETICS CORPORATION


                                                  By  s/ James L. Peterson
                                                      James L. Peterson
                                                      President

        Pursuant  to the  requirements  of the  Securities  Act  of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates indicated.
<TABLE>

                                                Title                                                Date

<S>                                             <C>                                                  <C>
s/ Sir Stuart Burgess                           Chairman of the Board of                             8/11/98
Sir Stuart Burgess                              Directors


s/ James L. Peterson                            President, Chief Executive                           8/11/98
James L. Peterson                               Officer, Director


s/ Ronald J. Ryan                               Senior Vice President of Finance                     8/11/98
Ronald J. Ryan                                  and Chief Financial Officer
                                                (Principal Financial and
                                                Accounting Officer)


s/ Yutaka Sakurada                              Senior Vice President -                              8/11/98
- ---------------------------------
Yutaka Sakurada                                 Haemonetics Corp., and
                                                President - Haemonetics Japan,
                                                Director


s/ Benjamin L. Holmes                           Director                                             8/11/98
Benjamin L. Holmes




</TABLE>



                                      - 7 -

<PAGE>


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

                       As independent public accountants, we hereby consent to
the incorporation by reference in this Registration Statement on Form S-8 of our
report dated April 23, 1998 included in Haemonetics  Corporation's Form 10-K for
the year ended March 28, 1998 and to all references to our Firm included in this
Registration Statement.
                                      ARTHUR ANDERSEN LLP

/s/Arthur Andersen LLP
Boston, Massachusetts,
        August 7, 1998


320904-1

                                      - 8 -


                             HAEMONETICS CORPORATION
                        1998 Employee Stock Purchase Plan

1.      Purpose
        It is the purpose of this 1998 Employee Stock Purchase Plan to provide a
means  whereby  eligible  employees  may purchase  Common  Stock of  Haemonetics
Corporation  (the  "Company")  through  payroll  deductions.  It is  intended to
provide a further  incentive for employees to promote the best  interests of the
Company and to  encourage  stock  ownership  by employees in order that they may
participate in the Company's economic growth.
        It is the intention of the Company that the Plan qualify as an 
"employee stock purchase plan" within the meaning of Section 423 of the 
Internal Revenue Code and the provisions of this Plan shall be construed in a 
manner consistent with the Code.

2.      Definitions
                The following words or terms,  when used herein,  shall have the
following respective meanings:
        (a)     "Plan" shall mean the 1998 Employee Stock Purchase Plan.
        (b)     "Company" shall mean Haemonetics Corporation, a Massachusetts 
                corporation.
        (c)     "Account" means the Employee Stock Purchase Account established 
                for a Participant under Section 7 hereunder.
        (d)     "Basic  Compensation"  shall mean the regular  rate of salary or
                wages  in  effect   immediately  prior  to  a  Purchase  Period,
                including   sales   commissions,   before  any   deductions   or
                withholdings,  but shall exclude  overtime,  bonuses and amounts
                paid in reimbursement for expenses.

                                      - 1 -

<PAGE>



        (e)     "Board of Directors" shall mean the Board of Directors of 
                Haemonetics Corporation.
        (f)     "Code" shall mean the Internal Revenue Code of 1986, as amended.
        (g)     "Committee" shall mean the Stock Purchase Plan Committee 
                appointed and acting in accordance with the terms of the Plan.
        (h)     "Common Stock" shall mean shares of the Company's common stock
                with a par value of $.01 per share.
        (i)     "Effective Date" shall mean May 1, 1998.
        (j)     "Eligible Employees" shall mean all persons employed by the 
                Company or one of its subsidiaries as defined in Section 424 
                of the Code, but excluding:
                (1)      Persons who have been employed by the Company or its 
                         subsidiaries for less than six months on the first day 
                         of the Purchase Period with the
                         exception of persons previously eligible;
                (2)      Persons whose customary employment is less than twenty 
                         hours per week or five months or less per year; and
                (3)      Persons   who  are  deemed  for   purposes  of  Section
                         423(b)(3)  of the Code to own  stock  possessing  5% or
                         more of the total combined voting power or value of all
                         classes  of  stock  of the  Company,  its  parent  or a
                         subsidiary.
        For  purposes  of the Plan,  employment  will be treated  as  continuing
intact while a Participant is on military leave,  sick leave, or other bona fide
leave of  absence,  for up to 90 days or so long as the  Participant's  right to
re-employment is guaranteed either by statute or by contract,  if longer than 90
days.

                                      - 2 -

<PAGE>



        (k)     "Exercise  Date"  shall mean the last day of a Purchase  Period;
                provided,  however,  that if such  date is not a  business  day,
                "Exercise  Date" shall mean the immediately  preceding  business
                day.
        (1)     "Participant"  shall  mean an  Eligible  Employee  who elects to
                participate in the Plan under Section 6 hereunder.
        (m)     Except as provided below,  there shall be two "Purchase Periods"
                in each full  calendar  year during which the Plan is in effect,
                one  commencing  on  November  1st of  each  calendar  year  and
                continuing  through  April  30 of such  calendar  year,  and the
                second   commencing  on  May  1st  of  each  calendar  year  and
                continuing through October 31st of such calendar year. The first
                Purchase  Period  after  adoption of the Plan shall  commence on
                November 1, 1998. The last Purchase Period shall commence on May
                1, 2008 and end on October 31, 2008.
        (n)     "Purchase Price" shall mean the lower of (i) 85% of the fair 
                market value of a share of Common Stock for the first business 
                day of the relevant Purchase Period, or (ii) 85% of such value 
                on the relevant Exercise Date.  If the shares of Common Stock
                are listed on any national securities exchange, or traded on 
                the National Association of Securities Dealers Automated 
                Quotation System ("NASDAQ") National Market System, the fair 
                market value per share of Common Stock on a particular day 
                shall be the closing price, if any, on the largest such 
                exchange, or if not traded on an exchange, the NASDAQ National 
                Market System, on such day, and, if there are no sales of the 
                shares of Common Stock on such particular day, the fair market 
                value of a share of Common Stock shall be determined by taking 
                a weighted average of the means between the highest and lowest 
                sales on the nearest date before and the

                                      - 3 -

<PAGE>



                nearest  date  after  the  particular  day  in  accordance  with
                Treasury Regulations Section 25.2512-2.  If the shares of Common
                Stock are not then  listed on any such  exchange  or the  NASDAQ
                National  Market  System,  the fair  market  value  per share of
                Common Stock on a  particular  day shall be the mean between the
                closing  "Bid"  and the  closing  "Asked"  prices,  if  any,  as
                reported in the National Daily  Quotation  Service for such day.
                If  the  fair  market  value  cannot  be  determined  under  the
                preceding sentences, it shall be determined in good faith by the
                Board of Directors.

3.      Grant of Option to Purchase Shares.
        Each Eligible Employee shall be granted an option effective on the first
day of each Purchase Period to purchase shares of Common Stock.  The term of the
option shall be the length of the Purchase Period.  The number of shares subject
to each option shall be the quotient of the aggregate payroll  deductions in the
Purchase  Period  authorized by each  Participant  in accordance  with Section 6
divided  by the  Purchase  Price,  but in no event  greater  than 800 shares per
option.  Notwithstanding  the  foregoing,  (i) no  employee  shall be granted an
option which  permits his right to purchase  shares under the Plan and under all
other Code Section  423(b)  employee  stock purchase plans of the Company or any
parent or  subsidiary  corporation  to accrue at a rate which exceeds in any one
calendar  year  $25,000 of the fair market  value of the Common  Stock as of the
date the option to purchase is granted. 4. Shares.
        There shall be 375,000  shares of Common Stock  reserved for issuance to
and purchase by  Participants  under the Plan,  subject to  adjustment as herein
provided.  The shares of Common Stock subject to the Plan shall be either shares
of authorized but unissued Common Stock or shares of Common Stock  reacquired by
the Company and held as treasury shares. Shares of

                                      - 4 -

<PAGE>



Common Stock not purchased under an option terminated pursuant to the provisions
of the Plan may again be subject to options granted under the Plan.
        The  aggregate  number of shares of Common  Stock which may be purchased
pursuant  to options  granted  hereunder,  the number of shares of Common  Stock
covered by each  outstanding  option,  the maximum  number of shares that may be
granted in any Purchase Period and the purchase price for each such option shall
be  appropriately  adjusted  for any  increase  or  decrease  in the  number  of
outstanding  shares  of  Common  Stock  resulting  from a stock  split  or other
subdivision  or  consolidation  of shares of Common  Stock or for other  capital
adjustments or payments of stock dividends or  distributions  or other increases
or decreases in the outstanding  shares of Common Stock effected without receipt
of consideration by the Company.
5.      Administration.
        The Plan  shall be  administered  by the Board of  Directors  or a Stock
Purchase Plan  Committee  appointed from time to time by the Board of Directors.
All members of the Committee  shall serve at the  discretion  of the Board.  The
Board of Directors or the Committee,  if one has been appointed,  is vested with
full  authority to make,  administer  and  interpret  such  equitable  rules and
regulations  regarding  the  Plan  as  it  may  deem  advisable.  The  Board  of
Directors', or the Committee's, if one has been appointed,  determinations as to
the interpretation  and operation of the Plan shall be final and conclusive.  No
member of the Board of Directors or the Committee shall be liable for any action
or  determination  made in good  faith  with  respect  to the Plan or any option
granted under the Plan. 6. Election to Participate.
        An Eligible Employee may elect to become a Participant in the Plan for a
Purchase  Period by completing a "Stock  Purchase  Agreement"  form prior to the
first day of the Purchase Period

                                      - 5 -

<PAGE>



for which the election is made.  Such Stock Purchase  Agreement shall be in such
form as shall be  determined  by the Board of  Directors or the  Committee.  The
election to participate  shall be effective for the Purchase Period for which it
is made.  There is no limit on the  number  of  Purchase  Periods  for  which an
Eligible  Employee may elect to become a  Participant  in the Plan. In the Stock
Purchase  Agreement,  the Eligible  Employee  shall  authorize  regular  payroll
deductions  of any full  percentage of his Basic  Compensation,  but in no event
less  than  two  percent  nor  more  than  eight   percent  (8%)  of  his  Basic
Compensation.  An Eligible Employee may not change his  authorization  except as
otherwise  provided in Section 9. Options granted to Eligible Employees who have
failed to execute a Stock Purchase  Agreement within the time periods prescribed
by the Plan will automatically lapse. 7. Employee Stock Purchase Account.
        An  Employee  Stock  Purchase  Account  will  be  established  for  each
Participant in the Plan for bookkeeping  purposes,  and payroll  deductions made
under  Section  6 will be  credited  to such  Accounts.  However,  prior  to the
purchase  of  shares  in  accordance  with  Section  8  or  withdrawal  from  or
termination of the Plan in accordance  with the provisions  hereof,  the Company
may  use  for  any  valid  corporate   purpose  all  amounts   deducted  from  a
Participant's wages under the Plan and credited for bookkeeping  purposes to his
Account.
        The  Company  shall be  under no  obligation  to pay  interest  on funds
credited  to a  Participant's  Account,  whether  upon  purchase  of  shares  in
accordance  with Section 8 or upon  distribution in the event of withdrawal from
or termination of the Plan as herein provided.
8.      Purchase of Shares.
        Each Eligible  Employee who is a Participant  in the Plan  automatically
and without any act on his part will be deemed to have  exercised  his option on
each Exercise Date to the extent that

                                      - 6 -

<PAGE>



the balance then in his Account  under the Plan is sufficient to purchase at the
Purchase  Price whole  shares of the Common  Stock  subject to his  option.  Any
balance  remaining in the  Participant's  Account  shall be carried  forward and
credited for use in the next  Purchase  Period.  If the Employee  chooses not to
participate in the next Purchase Period,  any balance will be refunded to him in
cash.  Notwithstanding  the foregoing,  any balance remaining in a Participant's
Account  at the end of a  Purchase  Period  as a  result  of  aggregate  payroll
deductions  having  exceeded  the  limitations  set forth in  Section 3 shall be
refunded to the Participant in cash without interest. 9. Withdrawal.
        A Participant  who has elected to authorize  payroll  deductions for the
purchase of shares of Common Stock may cancel his election by written  notice of
cancellation  delivered  to the office or person  designated  by the  Company to
receive  Stock  Purchase  Agreements  ("Cancellation"),  but any such  notice of
Cancellation  must be so  delivered  not  later  than ten (10) days  before  the
relevant Exercise Date.
        A  Participant  will  receive  in  cash,  as soon as  practicable  after
delivery of the notice of Cancellation,  the amount credited to his Account. Any
Participant who so withdraws from the Plan may again become a Participant at the
start of the next Purchase Period in accordance with Section 6.
        Upon   dissolution  or  liquidation  of  the  Company  or  a  merger  or
consolidation  in which the Company is not the  surviving  entity  every  option
outstanding hereunder shall terminate,  in which event each Participant shall be
refunded the amount of cash then in his Account.
10.     Issuance of Stock Certificates.

                                      - 7 -

<PAGE>



        The shares of Common Stock  purchased by a  Participant  shall,  for all
purposes, be deemed to have been issued and sold at the close of business on the
Exercise  Date.  Prior  to that  date  none of the  rights  or  privileges  of a
stockholder  of the Company,  including the right to vote or receive  dividends,
shall exist with respect to such shares.
        Within a reasonable  time after the  Exercise  Date,  the Company  shall
issue  and  deliver a  certificate  for the  number  of  shares of Common  Stock
purchased by a Participant for the Purchase Period,  which  certificate shall be
registered  either  in the  Participant's  name,  jointly  in the  names  of the
Participant  and his spouse,  or in the name of the Participant or his spouse as
guardian for their  children,  as the  Participant  shall designate in his Stock
Purchase Agreement. Such designation may be changed at any time by filing notice
thereof with the party  designated by the Company to receive such  notices.  11.
Termination of Employment.
        (a)     Upon a  Participant's  termination of employment for any reason,
                other  than  death,  no payroll  deduction  may be made from any
                compensation  due him and the  entire  balance  credited  to his
                Account shall be automatically refunded.
        (b)     Upon the death of a Participant,  no payroll  deduction shall be
                made from any  compensation  due him at time of  death,  and the
                entire  balance in the deceased  Participant's  Account shall be
                paid in cash to the  Participant's  designated  beneficiary,  if
                any, under a group  insurance plan of the Company  covering such
                employee, or otherwise to his estate.
12.     Rights Not Transferable.
        The  right to  purchase  shares  of  Common  Stock  under  this  Plan is
exercisable only by the Participant  during his lifetime and is not transferable
by him. If a Participant attempts to transfer

                                      - 8 -

<PAGE>



his  right to  purchase  shares  under  the  Plan,  he shall be  deemed  to have
requested  withdrawal from the Plan and the provisions of Section 9 hereof shall
apply with respect to such Participant.
13.     No Guarantee of Continued Employment.
        Granting of an option  under this Plan shall imply no right of continued
employment with the Company for any Eligible Employee.
14.     Notice.
        Any notice which an Eligible  Employee or Participant  files pursuant to
this Plan  shall be in  writing  and shall be  delivered  personally  or by mail
addressed to Haemonetics  Corporation,  400 Wood Road, Braintree,  Massachusetts
02184 Attn: Alicia R. Lopez,  General Counsel. Any notice to a Participant or an
Eligible  Employee  shall be  conspicuously  posted in the  Company's  principal
office or shall be mailed  addressed to the Participant or Eligible  Employee at
the  address  designated  in the Stock  Purchase  Agreement  or in a  subsequent
writing.
15.     Application of Funds.
        All funds  deducted  from a  Participant's  wages in payment  for shares
purchased or to be purchased under this Plan may be used for any valid corporate
purpose  provided  that the  Participant's  Account  shall be credited  with the
amount of all  payroll  deductions  as  provided  in Section  7. 16.  Government
Approvals or Consents.
        This Plan and any offering and sales to Eligible  Employees under it are
subject  to any  governmental  approvals  or  consents  that  may  be or  become
applicable in connection therewith. Subject to the provisions of Section 17, the
Board of  Directors of the Company may make such changes in the Plan and include
such terms in any offering under this Plan as may be necessary

                                      - 9 -

<PAGE>



or desirable, in the opinion of counsel, to comply with the rules or regulations
of any governmental authority, or to be eligible for tax benefits under the Code
or the laws of any state.
17.     Amendment of the Plan.
        The Board of  Directors  may,  without the consent of the  Participants,
amend the Plan at any time,  provided that no such action shall adversely affect
options theretofore  granted hereunder,  and provided that no such action by the
Board of  Directors  without  approval of the  Company's  stockholders  may: (a)
increase  the total  number of shares of Common  Stock which may be purchased by
all  Participants;  or (b) change  the class of  employees  eligible  to receive
options under the Plan.
        For purposes of this Section 17, termination of the Plan by the Board of
Directors  pursuant  to  Section  18 shall not be  deemed to be an action  which
adversely affects options theretofore granted hereunder.
        18.     Term of the Plan.
        The Plan shall become effective on the Effective Date,  provided that it
is approved  within twelve months after  adoption by the Board of Directors at a
duly-held  stockholder's  meeting  by  stockholders  of the  Company  holding  a
majority  of the  Company's  voting  stock.  The Plan shall  continue  in effect
through October 31, 2008, provided,  however,  that the Board of Directors shall
have the right to terminate the Plan at any time. In the event of the expiration
of the Plan or its  termination,  all options  then  outstanding  under the Plan
shall  automatically  be cancelled and the entire amount credited to the Account
of each Participant hereunder shall be refunded to each such Participant.

                                     - 10 -

<PAGE>



        19.     Withholding of Additional Income Taxes.
        By electing to participate in the Plan,  each  Participant  acknowledges
that the  Company is  required  to  withhold  taxes with  respect to the amounts
deducted from the Participant's  compensation and accumulated for the benefit of
the Participant under the Plan and each Participant  agrees that the Company may
deduct additional amounts from the Participant's compensation,  when amounts are
added to the Participant's  account,  used to purchase Common Stock or refunded,
in order to satisfy  such  withholding  obligations.  Each  Participant  further
acknowledges that when Common Stock is purchased under the Plan, the Company may
be required to withhold taxes with respect to all or a portion of the difference
between the fair market  value of the Common  Stock  purchased  and its purchase
price,  and each  Participant  agrees  that  such  taxes  may be  withheld  from
compensation  otherwise  payable to such  Participant.  It is intended  that tax
withholding  will be  accomplished  in such a manner  that the  full  amount  of
payroll  deductions  elected by the Participant  under Section 6 will be used to
purchase Common Stock.  However, if amounts sufficient to satisfy applicable tax
withholding  obligations  have not been  withheld  from  compensation  otherwise
payable to any  Participant,  then,  notwithstanding  any other provision of the
Plan,  the Company may withhold  such taxes from the  Participant's  accumulated
payroll  deductions  and apply the net amount to the  purchase of Common  Stock,
unless the  Participant  pays to the  Company,  prior to the exercise  date,  an
amount  sufficient to satisfy such  withholding  obligations.  Each  Participant
further  acknowledges  that the Company  may be  required  to withhold  taxes in
connection with the disposition of stock acquired under the Plan and agrees that
the Company may take whatever  action it considers  appropriate  to satisfy such
withholding  requirements,   including  deducting  from  compensation  otherwise
payable to such  Participant  an amount  sufficient to satisfy such  withholding
requirements or conditioning

                                     - 11 -

<PAGE>


any  disposition  of Common  Stock by the  Participant  upon the  payment to the
Company of an amount sufficient to satisfy such withholding requirements.
20.     General.
        Whenever the context of this Plan permits,  the  masculine  gender shall
include the feminine and neuter genders.

295742-1

                                     - 12 -





                                                          August 11, 1998


Haemonetics Corporation
400 Wood Road
Braintree, MA 02184

Ladies and Gentlemen:

         We are counsel to Haemonetics Corporation,  a Massachusetts Corporation
(the  "Company"),  and as  such  counsel  we are  familiar  with  the  corporate
proceedings taken in connection with the adoption of the Company's 1998 Employee
Stock  Purchase  Plan (the "Plan").  We are also familiar with the  Registration
Statement  on Form S-8 to which a copy of this  opinion  will be  attached as an
exhibit.

         As such counsel,  we have examined the corporate records of the Company
including its Restated Articles of Organization, as amended, By-laws, Minutes of
Meetings of its Board of Directors and  Stockholders and such other documents as
we have deemed necessary as a basis for the opinions herein expressed.

         Based  upon  the  foregoing,   and  having  regarding  for  such  legal
considerations as we deem relevant, we are of the opinion that:

         1.       The Company is validly existing as a corporation and in good 
corporate standing under the laws of the Commonwealth of Massachusetts.

         2.       The Company has duly authorized the issuance of 80,000,000 
shares of common stock, $.01 par value per share ("Common Stock").

         3. The shares of Common Stock  issuable  pursuant to the Plan have been
duly authorized,  and when issued in accordance with the terms of the Plan, such
shares will be validly issued,  fully paid and  nonassessable  shares of capital
stock of the Company to which no personal liability will attach.

         We hereby  consent to the  filing of this  opinion as an exhibit to the
Registration  Statement  on Form S-8 and to  reference  to us under the  caption
"Interest of Named Experts and Counsel" in the Registration Statement.

                                     Very truly yours,

                                     /s/Hutchins, Wheeler & Dittmar
 
                                     Hutchins, Wheeler & Dittmar
                                     A Professional Corporation

MEO:smt:335354-1


<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission